UPDATE : Tuesday, November 12, 2019
Drugmakers rush to attend JP Morgan’s healthcare event
Many local pharmaceutical and biotech companies plan to attend J.P. Morgan’...
by So Jae-hyeon  |  2018-01-08 11:44
Celltrion stocks jump on expectations of rising market share
Investors are paying attention to Celltrion, the local leader in the develo...
by Lee Han-soo  |  2018-01-04 16:40
Venture capital investment in biomedical sector drops 20% in 2017
Venture capital investment in the local biomedical sector declined by 20 pe...
by Nam Doo-hyun  |  2018-01-04 09:30
Samyang Biopharm wins patent suit against Helsinn Healthcare
Samyang Biopharm said Wednesday that it has won a patent suit on Palseron (...
by Lee Han-soo  |  2018-01-03 16:58
70% of biotech firms enjoy stock price gains in 2017
In the South Korean stock market, biopharmaceutical and pharmaceutical firm...
by Nam Doo-hyun  |  2018-01-02 17:42
HanAll vice chairman sells off stake despite export deal
HanAll Biopharma Vice Chairman Kim Sung-wuk unexpectedly sold off part of h...
by So Jae-hyeon  |  2018-01-02 13:57
Kolon Life Science’s shares plummet on drifting export deal
Kolon Life Science’s shares plummeted by 15 percent on Wednesday from the p...
by Nam Doo-hyun  |  2017-12-21 13:16
HanAll inks $30 million tech export deal
HanAll Biopharma said it signed a $30 million deal with a U.S. company to t...
by So Jae-hyeon  |  2017-12-20 15:49
₩500-billion Invossa technology export to Japan in peril
Mitsubishi Tanabe Pharma notified Kolon Life Science that the Japanese drug...
by Nam Doo-hyun  |  2017-12-20 14:59
FDA to review Samsung Bioepis’ trastuzumab biosimilar
Samsung Bioepis said Tuesday that the U.S. Food and Drug Administration (FD...
by Lee Han-soo  |  2017-12-20 14:37
Nature Cell expects to receive conditional approval for Jointstem
Nature Cell showed confidence in obtaining conditional approval for Jointst...
by Lee Han-soo  |  2017-12-19 18:22
‘Celltrion’s annual revenue to top ₩3 trillion in 5 years’
Celltrion, which recently obtained Europe’s approval for breast cancer trea...
by Nam Doo-hyun  |  2017-12-18 15:55
Samsung Bioepis, Daewoong sign exclusive supply contract for Samfenet
Samsung Bioepis and Daewoong Pharmaceuticals have signed an exclusive suppl...
by Lee Han-soo  |  2017-12-18 10:59
Corestem’s NeuroNata-R marks increase in foreign patients
The number of foreign patients visiting Korea to use Corestem’s NeuroNata-R...
by Lee Han-soo  |  2017-12-15 16:22
FDA approves Pfizer’s Remicade biosimilar
Pfizer said Wednesday that it received U.S. Food and Drug Administration’s ...
by Lee Han-soo  |  2017-12-14 17:16
Samsung BioLogics’ 2nd factory gets European approval
Samsung BioLogics said Thursday that its second factory received manufactur...
by Lee Han-soo  |  2017-12-14 10:52
‘Surge of gene-therapy providing hospitals to benefit Invossa’
With hospitals increasingly registering as a provider of gene therapies, Ko...
by Nam Doo-hyun  |  2017-12-12 15:59
PCL shares rise despite regulator’s warning
Shares of PCL, a provider of in vitro diagnostic products, have risen again...
by Nam Doo-hyun  |  2017-12-12 11:02
Oscotec shares rebound on launch of US clinical trial
Shares of Oscotec rebounded on Monday on the company’s announcement that it...
by Nam Doo-hyun  |  2017-12-11 15:50
ToolGen’s shares jump on gene therapy market expectations
With rising expectations for a rapid growth of gene therapy market, investo...
by Nam Doo-hyun  |  2017-12-11 15:16
Back to Top